{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:19:29Z","timestamp":1648700369650},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.2169\/internalmedicine.2179-18","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T22:03:23Z","timestamp":1569449003000},"page":"383-388","source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Amiodarone-induced Thyrotoxicosis Type 1 in Combination with Methimazole and Potassium Iodide in a Patient with Hashimoto's Thyroiditis"],"prefix":"10.2169","volume":"59","author":[{"given":"Daisuke","family":"Katoh","sequence":"first","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Ikehara","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kumashiro","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Uchino","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Hirose","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 118: 706-714, 2005.","DOI":"10.1016\/j.amjmed.2004.11.028"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F. The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. Eur J Endocrinol 171: 363-368, 2014.","DOI":"10.1530\/EJE-14-0267"},{"key":"3","unstructured":"3. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J 7: 55-66, 2018."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95: 2529-2535, 2010.","DOI":"10.1210\/jc.2010-0180"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sato K, Miyakawa M, Eto M, et al. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. Endocr J 46: 443-451, 1999.","DOI":"10.1507\/endocrj.46.443"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sato K, Omi Y, Kodama H, et al. Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia. Intern Med 47: 757-762, 2008.","DOI":"10.2169\/internalmedicine.47.0843"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Uchida T, Kasai T, Takagi A, et al. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. Int J Endocrinol 2014: 534904, 2014.","DOI":"10.1155\/2014\/534904"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 27: 315-389, 2017.","DOI":"10.1089\/thy.2016.0457"},{"key":"9","unstructured":"9. Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther 27: 191-203, 2010."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 9: 705-713, 1999.","DOI":"10.1089\/thy.1999.9.705"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Ide A, Amino N, Kang S, et al. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid 24: 1027-1031, 2014.","DOI":"10.1089\/thy.2013.0585"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 6: 34-41, 2010.","DOI":"10.1038\/nrendo.2009.225"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 22: 240-254, 2001.","DOI":"10.1210\/edrv.22.2.0427"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Khan A, Puttanna A, Raskauskiene D. Amiodarone-induced thyrotoxicosis: type 1 or type 2? BMJ Case Rep 2014: 2014.","DOI":"10.1136\/bcr-2014-204485"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Cooper DS. Hyperthyroidism. Lancet 362: 459-468, 2003.","DOI":"10.1016\/S0140-6736(03)14073-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hiraiwa T, Tsujimoto N, Tanimoto K, Terasaki J, Amino N, Hanafusa T. Use of color Doppler ultrasonography to measure thyroid blood flow and differentiate graves' disease from painless thyroiditis. Eur Thyroid J 2: 120-126, 2013.","DOI":"10.1159\/000350560"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Bogazzi F, Bartalena L, Brogioni S, et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7: 541-545, 1997.","DOI":"10.1089\/thy.1997.7.541"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sugimoto T, Momotani N, Iino S, Ito K. [Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease]. Nihon Naibunpi Gakkai Zasshi (Jpn J Endocrinol) 70: 1083-1092, 1994 (in Japanese, Abstract in English).","DOI":"10.1507\/endocrine1927.70.10_1083"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Giovacchini G, Giovanella L, Haldemann A, Staub U, Fuchsel FG, Koch P. Potentiometric measurement of urinary iodine concentration in patients with thyroid diseases with and without previous exposure to non-radioactive iodine. Clin Chem Lab Med 53: 1753-1760, 2015.","DOI":"10.1515\/cclm-2015-0117"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shigemasa C, Abe K, Taniguchi S, et al. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. J Clin Endocrinol Metab 65: 359-363, 1987.","DOI":"10.1210\/jcem-65-2-359"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wartofsky L, Ransil BJ, Ingbar SH. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 49: 78-86, 1970.","DOI":"10.1172\/JCI106225"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takata K, Amino N, Kubota S, et al. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol 72: 845-850, 2010.","DOI":"10.1111\/j.1365-2265.2009.03745.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 91: 507-511, 1991.","DOI":"10.1016\/0002-9343(91)90187-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ahmed S, Van Gelder IC, Wiesfeld AC, Van Veldhuisen DJ, Links TP. Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol 75: 388-394, 2011.","DOI":"10.1111\/j.1365-2265.2011.04087.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Raghavan RP, Taylor PN, Bhake R, et al. Amiodarone-induced thyrotoxicosis, an overview of UK management. Clin Endocrinol 77: 936-937, 2012.","DOI":"10.1111\/j.1365-2265.2012.04435.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_2179-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:43:26Z","timestamp":1580528606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_2179-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2179-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}